乳腺癌风险与MRI全自动量化背景实质强化之间的关联:IMAGINE研究
这项前瞻性病例对照研究纳入美国三家中心2010年11月至2017年7月接受双侧乳腺MRI检查的患者,用全自动软件量化乳腺体积、纤维腺体组织体积和背景实质强化。BPE范围与BI-RADS BPE类别正相关(rs=0.54,P<.001)。与低BPE范围相比,高BPE范围与乳腺癌风险升高相关(OR 1.74,95%CI 1.23–2.46;趋势P=.002),绝经前和绝经后女性相似(OR分别为1.75和1.83,交互P=.73)。
要点
- 全自动量化的BPE范围与BI-RADS BPE主观分级正相关(rs=0.54,P<.001)。
- 高BPE范围(50.7%-97.3%)较低BPE范围(2.9%-34.2%)乳腺癌风险升高(OR 1.74,95%CI 1.23–2.46)。
- 高BPE范围与乳腺癌风险升高的关联在绝经前和绝经后女性中相似(OR分别为1.75和1.83)。
核心结论
- 乳腺MRI全自动量化的BPE与乳腺癌风险升高相关,且绝经前和绝经后女性中均存在此关联。
研究设计与样本
- 前瞻性病例对照研究,纳入2010年11月至2017年7月美国三家中心接受双侧乳腺MRI检查的患者,共536例乳腺癌患者和940例无癌对照;使用全自动软件量化乳腺体积、纤维腺体组织体积和BPE。
诊断标准与关键数值
- BPE范围定义为纤维腺体组织体素中强化程度达到20%及以上的比例。
- BPE范围与BI-RADS BPE类别呈正相关(rs=0.54,P<.001)。
- 与低BPE范围(2.9%-34.2%)相比,高BPE范围(50.7%-97.3%)与乳腺癌风险升高相关(OR 1.74,95%CI 1.23–2.46;趋势P=.002)。
- 在多变量模型中,纤维腺体组织体积与乳腺癌风险相关(OR 1.39,95%CI 0.97–1.98),脂肪体积与乳腺癌风险相关(OR 1.46,95%CI 1.04–2.06)。
- 绝经前女性高BPE范围的OR为1.75,绝经后女性为1.83,交互作用P=.73。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Background Background parenchymal enhancement (BPE) at breast MRI has been associated with increased breast cancer risk in several independent studies. However, variability of subjective BPE assessments have precluded its use in clinical practice. Purpose To examine the association between fully objective measures of BPE at MRI and odds of breast cancer. Materials and Methods This prospective case-control study included patients who underwent a bilateral breast MRI examination and were receiving care at one of three centers in the United States from November 2010 to July 2017. Breast volume, fibroglandular tissue (FGT) volume, and BPE were quantified using fully automated software. Fat volume was defined as breast volume minus FGT volume. BPE extent was defined as the proportion of FGT voxels with enhancement of 20% or more. Spearman rank correlation between quantitative BPE extent and Breast Imaging Reporting and Data System (BI-RADS) BPE categories assigned by an experienced board-certified breast radiologist was estimated. With use of multivariable logistic regression, breast cancer case-control status was regressed on tertiles (low, moderate, and high) of BPE, FGT volume, and fat volume, with adjustment for covariates. Results In total, 536 case participants with breast cancer (median age, 48 years [IQR, 43-55 years]) and 940 cancer-free controls (median age, 46 years [IQR, 38-55 years]) were included. BPE extent was positively associated with BI-RADS BPE (rs = 0.54; P < .001). Compared with low BPE extent (range, 2.9%-34.2%), high BPE extent (range, 50.7%-97.3%) was associated with increased odds of breast cancer (odds ratio [OR], 1.74 [95% CI: 1.23, 2.46]; P for trend = .002) in a multivariable model also including FGT volume (OR, 1.39 [95% CI: 0.97, 1.98]) and fat volume (OR, 1.46 [95% CI: 1.04, 2.06]). The association of high BPE extent with increased odds of breast cancer was similar for premenopausal and postmenopausal women (ORs, 1.75 and 1.83, respectively; interaction P = .73). Conclusion Objectively measured BPE at breast MRI is associated with increased breast cancer odds for both premenopausal and postmenopausal women. Clinical trial registration no. NCT02301767 © RSNA, 2023 Supplemental material is available for this article. See also the editorial by Bokacheva in this issue.
引用
- Watt GP, Thakran S, Sung JS, et al. Association of Breast Cancer Odds with Background Parenchymal Enhancement Quantified Using a Fully Automated Method at MRI: The IMAGINE Study. Radiology. 2023. PMID: 37750771. doi:10.1148/radiol.230367
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。